N. Turjanski et al., PET STUDIES OF THE PRESYNAPTIC AND POSTSYNAPTIC DOPAMINERGIC SYSTEM IN TOURETTES-SYNDROME, Journal of Neurology, Neurosurgery and Psychiatry, 57(6), 1994, pp. 688-692
Dysfunction of the dopaminergic pathway has been postulated to underli
e the symptomatology of Tourette's syndrome. Presynaptic functional in
tegrity of dopaminergic terminals was assessed with F-18-dopa PET in 1
0 patients with Tourette's syndrome, three of whom were drug free and
seven of whom were on neuroleptic treatment. Dopamine D-2 receptor sit
e density was measured with C-11-raclopride PET in a further group of
five drug free patients with Tourette's syndrome. Mean caudate and put
amen F-18-dopa influx constants were similar in patients with Tourette
's syndrome and controls, and there was no difference in F-18-dopa upt
ake between the and untreated Tourette's syndrome groups. Mean caudate
and putamen C-11-raclopride binding potentials in patients with Toure
tte's syndrome were also similar to control values. The findings sugge
st that striatal metabolism of exogenous levodopa and the density of s
triatal D-2 receptors are both normal in patients with Tourette's synd
rome and that Tourette's syndrome does not arise fi om a primary dysfu
nction of dopaminergic terminals.